glp-1 employer healthcare costs How Employers Can Manage in Their Health Plans GLP-1 employer costs, cut spend

Like all medications, GLP-1 drugs such as Ozempic and Wegovy can come with side effects

At its highest dose, 36 mg, participants in a phase 3 trial lost an average of 12.4 percent of their starting weight over 72 weeks

More research is ongoing

The medication is contraindicated in patients with uncontrolled hypertension, seizure disorders, or current use of MAO inhibitors

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice